Overview

A 1999 report presented OXiGENE Inc., a small pharmaceutical firm at the leading edge of a new model for its industry, leveraging IT and strategic outsourcing to compete with firms possessing much larger resources.  In that report, Scott Young, then Director of Regulatory Affairs/Operations, now Chief Operating Officer at OXiGENE, made several predictions about the impact of IT and outsourcing on time-to-market in the pharmaceutical industry. Five years later, we asked Young to revisit his predictions and update us on the progress of OXiGENE's model.  He reports that, although enabling technologies have become more sophisticated and more widespread over the past five years, it is still too early to see measurable time-savings from them.
(6 pages)

You have attempted to access an area of the Management Roundtable site that requires you to be signed in or to have a different level of access.

Please log in with your email address and password below. If you are not a member, you may join Management Roundtable for additional benefits.

E-mail

Password Sign in

Forgotten your password? Click here to request your password

SPECIAL NO-RISK OFFER

Now you can try FastTrack for yourself. For just $89, you can access everything on FastTrack for 6 weeks. At the end of your introductory membership, you can renew your membership for a full year at the regular rate of $495 per year. If you're not 100% satisfied with your membership, simply contact us to receive a full refund!
 

OPTION 1	OPTION 2
OPTION 3 Not ready to commit yet? Become a registered user of Fast Track for free. Every month we make exclusive Fast Track articles available to our registered users.

 

 

---